Thus, TAK1 activation can occur at all layers of cellular signal transduction, spanning from the membrane proximal layer of receptor–ligand interactions to cytoplasmic signalosome assembly, to result in varied outcomes and phenotypes found in multiple types of cancer. This evidence concerns the gene MAP3K7 and cancer.